Evaluation of COVA™+ CARD in Adult Cardiac Surgery
- Conditions
- SafetyTolerance
- Registration Number
- NCT03140098
- Lead Sponsor
- Biom'Up France SAS
- Brief Summary
The aim of this observational study is to evaluate the safety of the guided healing and adhesion prevention membrane, COVA™+ CARD, in adult cardiac surgery. The causality of the collagen membrane according to the occurrence of peri and post-operative complications will be evaluated.
- Detailed Description
Assessment of the safety of COVA™+ CARD, collagen membrane to prevent adhesion appearance, in cardiac surgery in adult patients:
* collection of post-operative complications, causality of the membrane
* collection of complications in the 3-month period after the surgery, causality of the membrane
* collection of peri-operative complications, causality of the membrane
* collection of complications, 3 months after the surgery
* assessment of the efficacy of COVA™+ CARD if re-operation
* assessment of the surgeon's satisfaction
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- 18 years of age or older
- Cardiac surgery using COVA™+ CARD
- In accordance with the instruction for use (IFU) of the medical device.
- Refusal of participation to the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the tolerance of COVA™+ CARD in cardiac surgery 3 months Recording of complications reported in the 3-month postoperative period and determination of the causality of the collagen membrane.
- Secondary Outcome Measures
Name Time Method Evaluation of the tolerance of COVA™+ CARD in cardiac surgery Hospitalization stay (up to 30 days) Recording of the immediate postoperative complications and determination of the causality of the collagen membrane.